Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 16, keine Gesamtzahl für „substrate“
Suchtreffer
Begriffe & Kennungen
Ibrance · 4.5 · The dose of sensitive CYP3A substrates with a narrow therapeutic index (e.g., alfentanil, cyclosporine, dihydr
Eintrag öffnenIbrance · 4.5 · The dose of sensitive CYP3A substrates with a narrow therapeutic index (e.g., alfentanil, cyclosporine, dihydr
Eintrag öffnenIcandra (previously Vildagliptin / metformin hydrochloride Novartis) · 4.5 · Drug-drug interaction studies with digoxin (P-glycoprotein substrate) and warfarin (CYP2C9 substrate) in healt
Eintrag öffnenIclusig · 4.5 · Transporter substrates In vitro, ponatinib is an inhibitor of P-gp and BCRP. Therefore, ponatinib may have the
Eintrag öffnenIclusig · 4.5 · Transporter substrates In vitro, ponatinib is an inhibitor of P-gp and BCRP. Therefore, ponatinib may have the
Eintrag öffnenIcotyde · 4.5 · Based on in vitro studies, icotrokinra is not a CYP enzyme substrate, inhibitor, or inducer. Icotrokinra is no
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.5 · Pomalidomide is partly metabolised by CYP1A2 and CYP3A4/5. It is also a substrate for P-glycoprotein. Co-admin
Eintrag öffnenInaqovi · 4.5 · Because decitabine is a substrate for the cytidine deaminase (CDA) enzyme, which metabolises decitabine result
Eintrag öffnenInaqovi · 4.5 · Decitabine and cedazuridine are not substrates or inhibitors for cytochrome P450 (CYP450); thus interactions w
Eintrag öffnenIncruse Ellipta (previously Incruse) · 4.5 · Umeclidinium is a substrate of P-glycoprotein (P-gp) transporter. The effect of the moderate P- gp inhibitor v
Eintrag öffnenIncruse Ellipta (previously Incruse) · 4.5 · Umeclidinium is a substrate of cytochrome P450 2D6 (CYP2D6). The steady-state pharmacokinetics of umeclidinium
Eintrag öffnenInsulin-Rezeptor-Substrat-Proteine
Eintrag öffnenIqirvo · 4.5 · CYP2C9 substrates (Warfarin):
Eintrag öffnenIqirvo · 4.5 · CYP3A4 substrates Based on clinical studies conducted , elafibranor may be a mild CYP3A4 inducer. A clinical i
Eintrag öffnenIscover · 4.5 · CYP2C8 substrate medicinal products: Clopidogrel has been shown to increase repaglinide exposure in healthy vo
Eintrag öffnenIsentress · 4.5 · In vitro studies indicate that raltegravir is not a substrate of cytochrome P450 (CYP) enzymes, does not inhib
Eintrag öffnenIsentress · 4.5 · In vitro studies indicate that raltegravir is not a substrate of cytochrome P450 (CYP) enzymes, does not inhib
Eintrag öffnenIsentress · 4.5 · In vitro studies indicate that raltegravir is not a substrate of cytochrome P450 (CYP) enzymes, does not inhib
Eintrag öffnenIsentress · 4.5 · In vitro studies indicate that raltegravir is not a substrate of cytochrome P450 (CYP) enzymes, does not inhib
Eintrag öffnenJalra · 4.5 · Digoxin (Pgp substrate), warfarin (CYP2C9 substrate)
Eintrag öffnen